- increased circulating amylase level / IMPC
- decreased circulating calcium level / IMPC
- decreased circulating iron level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating total protein level / IMPC
- decreased circulating glycerol level / IMPC
- increased circulating aspartate transaminase level / IMPC
- decreased circulating cholesterol level / IMPC
- thrombocytosis / IMPC
- decreased circulating LDL cholesterol level / IMPC
C57BL/6N-Sidt2tm2a(KOMP)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:14056 |
International strain name | C57BL/6N-Sidt2tm2a(KOMP)Wtsi/WtsiH |
Alternative name | BEPD0131_D08 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Sidt2tm2a(KOMP)Wtsi |
Gene/Transgene symbol | Sidt2 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone BEPD0131_D08. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- abnormal liver morphology / MGI
- abnormal hepatocyte morphology / MGI
- decreased body weight / MGI
- decreased body size / MGI
- increased circulating triglyceride level / MGI
- hepatic necrosis / MGI
- liver inflammation / MGI
- no abnormal phenotype detected / MGI
- hepatic steatosis / MGI
- decreased circulating insulin level / MGI
- increased circulating alanine transaminase level / MGI
- liver fibrosis / MGI
- abnormal insulin secretion / MGI
- increased pancreatic beta cell number / MGI
- abnormal pancreatic beta cell morphology / MGI
- impaired glucose tolerance / MGI
- increased circulating aspartate transaminase level / MGI
- homeostasis/metabolism phenotype / MGI
- increased circulating glucose level / MGI
- increased liver triglyceride level / MGI
- abnormal endoplasmic reticulum morphology / MGI
- increased liver free fatty acids level / MGI
- increased endoplasmic reticulum stress / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).